The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
Open accessAbstract
Despite gains in survival, outcomes for patients with metastatic or recurrent rhabdomyosarcoma remain dismal. In a collaboration between the National Cancer Institute, Children's Oncology Group, and Broad Institute, we performed whole-genome, whole-exome, and transcriptome sequencing to characterize the landscape of somatic alterations in 147 tumor/normal pairs. Two genotypes are evident in rhabdomyosarcoma tumors: those characterized by the PAX3 or PAX7 fusion and those that lack these fusions but harbor mutations in key signaling pathways. The overall burden of somatic mutations in rhabdomyosarcoma is relatively low, especially in tumors that harbor a PAX3/7 gene fusion. In addition to previously reported mutations in NRAS, KRAS, HRAS, FGFR4, PIK3CA, and CTNNB1, we found novel recurrent mutations in FBXW7 and BCOR, providing potential new avenues for therapeutic intervention. Furthermore, alteration of the receptor tyrosine kinase/RAS/PIK3CA axis affects 93% of cases, providing a framework for genomics-directed therapies that might improve outcomes for patients with rhabdomyosarcoma. Significance: This is the most comprehensive genomic analysis of rhabdomyosarcoma to date. Despite a relatively low mutation rate, multiple genes were recurrently altered, including NRAS, KRAS, HRAS, FGFR4, PIK3CA, CTNNB1, FBXW7, and BCOR. In addition, a majority of rhabdomyosarcoma tumors alter the receptor tyrosine kinase/RAS/PIK3CA axis, providing an opportunity for genomics-guided intervention. Cancer Discov; 4(2); 216–31. ©2014 AACR. This article is highlighted in the In This Issue feature, p. 131
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504
Self-citationThe clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967 · cited 1×
“Our observation that 58% of the verified somatic mutations discovered at the DNA level had evidence of RNA expression is a higher proportion than the 36% rate observed in adult cancers such as breast cancer (42) or lymphoma (43), and may reflect an enrichment of driver mutations or the presence of fewer accumulated pa…”
Reactome: a database of reactions, pathways and biological processes
Croft, D., O'Kelly, G., Wu, G., Haw, R., Gillespie, M., Matthews, L., Caudy, M., Garapati, P., Gopinath, G., Jassal, B., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1018 · Cited by 1,751 · cited 2×
“org/) was performed as previously described (24).”
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596 · cited 1×
“The background mutation rate was calculated using the method described by Zhang and colleagues (47).”
Self-citationExome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J.-P., White, T. A., Stojanov, P., Van Allen, E., Stransky, N., et al. (2012) · Nature Genetics · doi:10.1038/ng.2279 · Cited by 1,558
Self-citationInitial genome sequencing and analysis of multiple myeloma
Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,433
Self-citationHuman Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
Drmanac, R., Sparks, A. B., Callow, M. J., Halpern, A. L., Burns, N. L., Kermani, B. G., Carnevali, P., Nazarenko, I., Nilsen, G. B., Yeung, G., et al. (2010) · Science · doi:10.1126/science.1181498 · Cited by 1,212 · cited 1×
“For WGS, approximately 6 μg (range, 5–10 μg) of native genomic DNA was sequenced according to the Complete Genomics method (46).”
Self-citationThe genetic landscape of high-risk neuroblastoma
Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2529 · Cited by 1,186
Self-citationTopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Kim, D., & Salzberg, S. L. (2011) · Genome Biology · doi:10.1186/gb-2011-12-8-r72 · Cited by 809
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Pugh, T. J., Weeraratne, S. D., Archer, T. C., Pomeranz Krummel, D. A., Auclair, D., Bochicchio, J., Carneiro, M. O., Carter, S. L., Cibulskis, K., Erlich, R. L., et al. (2012) · Nature · doi:10.1038/nature11329 · Cited by 750
Self-citationSorensen, P. H. B., Lynch, J. C., Qualman, S. J., Tirabosco, R., Lim, J. F., Maurer, H. M., Bridge, J. A., Crist, W. M., Triche, T. J., & Barr, F. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.137 · Cited by 742
Self-citationAscierto, P. A., Schadendorf, D., Berking, C., Agarwala, S. S., van Herpen, C. M., Queirolo, P., Blank, C. U., Hauschild, A., Beck, J. T., St-Pierre, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70024-x · Cited by 640 · cited 1×
“Although directly targeting constitutively active RAS remains challenging, the recent success of the MAP–ERK kinase 1/2 (MEK1/2) inhibitor trametinib in melanomas with mutated NRAS demonstrates the utility of inhibiting the effector pathways altered by the mutation (38).”
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
Davis, R. J., D’Cruz, C. M., Lovell, M. A., Biegel, J. A., & Barr, F. G. (1994) · PubMed · Cited by 585
Self-citationdeFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
McPherson, A., Hormozdiari, F., Zayed, A., Giuliany, R., Ha, G., Sun, M. G. F., Griffith, M., Heravi Moussavi, A., Senz, J., Melnyk, N., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001138 · Cited by 557 · cited 1×
“3 (55) with hg19 human genome assembly.”
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma
Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., & Emanuel, B. S. (1993) · Nature Genetics · doi:10.1038/ng0293-113 · Cited by 555
Self-citationBFAST: An Alignment Tool for Large Scale Genome Resequencing
Homer, N., Merriman, B., & Nelson, S. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007767 · Cited by 529
A novel retinoblastoma therapy from genomic and epigenetic analyses
Zhang, J., Benavente, C. A., McEvoy, J., Flores-Otero, J., Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J., et al. (2012) · Nature · doi:10.1038/nature10733 · Cited by 516
Self-citationWilliamson, D., Missiaglia, E., de Reyniès, A., Pierron, G., Thuille, B., Palenzuela, G., Thway, K., Orbach, D., Laé, M., Fréneaux, P., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3814 · Cited by 502
Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005
Ognjanovic, S., Linabery, A. M., Charbonneau, B., & Ross, J. A. (2009) · Cancer · doi:10.1002/cncr.24465 · Cited by 497
BCoR, a novel corepressor involved in BCL-6 repression
Huynh, K. D., Fischle, W., Verdin, E., & Bardwell, V. J. (2000) · Genes & Development · doi:10.1101/gad.14.14.1810 · Cited by 477
American Association for Cancer Research
Salgaller, M. L. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.6.1413 · Cited by 473
Exome sequencing identifies GRIN2A as frequently mutated in melanoma
Program, N. C. S., Wei, X., Walia, V., Lin, J. C., Teer, J. K., Prickett, T. D., Gartner, J., Davis, S., Stemke-Hale, K., Davies, M. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.810 · Cited by 471
Breneman, J. C., Lyden, E., Pappo, A. S., Link, M. P., Anderson, J. R., Parham, D. M., Qualman, S. J., Wharam, M. D., Donaldson, S. S., Maurer, H. M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.129 · Cited by 470
Self-citationGene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.
Khan, J. I., Simon, R., Bittner, M. L., Chen, Y., Leighton, S. B., Pohida, T. J., Smith, P. D., Jiang, Y. Y., Gooden, G. C., Trent, J. M., et al. (1998) · PubMed · Cited by 437
Self-citationMalempati, S., & Hawkins, D. S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24118 · Cited by 422
Self-citationMissiaglia, E., Williamson, D., Chisholm, J., Wirapati, P., Pierron, G., Petel, F., Concordet, J.-P., Thway, K., Oberlin, O., Pritchard-Jones, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5591 · Cited by 365
Gearhart, M. D., Corcoran, C. M., Wamstad, J. A., & Bardwell, V. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00630-06 · Cited by 351
VI, J. G. T., Cheuk, A. T., Tsang, P. S., Chung, J.-Y., Song, Y. K., Desai, K., Yu, Y., Chen, Q.-R., Shah, K., Youngblood, V., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39703 · Cited by 321
Self-citationDavicioni, E., Graf Finckenstein, F., Shahbazian, V., Buckley, J. D., Triche, T. J., & Anderson, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4578 · Cited by 308
Keller, C., Arenkiel, B. R., Coffin, C. M., El-Bardeesy, N., DePinho, R. A., & Capecchi, M. R. (2004) · Genes & Development · doi:10.1101/gad.1244004 · Cited by 304
Skapek, S. X., Anderson, J., Barr, F. G., Bridge, J. A., Gastier-Foster, J. M., Parham, D. M., Rudzinski, E. R., Triche, T., & Hawkins, D. S. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24532 · Cited by 278
Self-citationGrossmann, V., Tiacci, E., Holmes, A. B., Kohlmann, A., Martelli, M. P., Kern, W., Spanhol-Rosseto, A., Klein, H.-U., Dugas, M., Schindela, S., et al. (2011) · Blood · doi:10.1182/blood-2011-07-365320 · Cited by 266
A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting.
Scrable, H., Cavenee, W., Ghavimi, F., Lovell, M., Morgan, K., & Sapienza, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7480 · Cited by 261
Petricoin, E. F., Espina, V., Araujo, R. P., Midura, B., Yeung, C., Wan, X., Eichler, G. S., Johann, D. J., Qualman, S., Tsokos, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1344 · Cited by 250
Wachtel, M., Dettling, M., Koscielniak, E., Stegmaier, S., Treuner, J., Simon-Klingenstein, K., Bühlmann, P., Niggli, F. K., & Schäfer, B. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0844 · Cited by 244
Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing
Reumers, J., De Rijk, P., Zhao, H., Liekens, A., Smeets, D., Cleary, J., Van Loo, P., Van Den Bossche, M., Catthoor, K., Sabbe, B., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2053 · Cited by 240
Cao, L., Yu, Y., Bilke, S., Walker, R. L., Mayeenuddin, L. H., Azorsa, D. O., Yang, F., Pineda, M., Helman, L. J., & Meltzer, P. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0582 · Cited by 239
Shukla, N., Ameur, N., Yilmaz, I., Nafa, K., Lau, C.-Y., Marchetti, A., Borsu, L., Barr, F. G., & Ladanyi, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2056 · Cited by 232
Self-citationSklar, C. A., Mertens, A. C., Walter, A. W., Mitchell, D. S., Nesbit, M. E., O’Leary, M., Hutchinson, R. J., Meadows, A. T., & Robison, L. L. (2000) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(200008)35:2<96::aid-mpo2>3.0.co;2-z · Cited by 214
Sequence-non-specific effects of RNA interference triggers and microRNA regulators
Olejniczak, M., Galka, P., & Krzyzosiak, W. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp829 · Cited by 202
Diskin, S. J., Eck, T., Greshock, J., Mosse, Y. P., Naylor, T., Stoeckert, C. J., Weber, B. L., Maris, J. M., & Grant, G. R. (2006) · Genome Research · doi:10.1101/gr.5076506 · Cited by 196
PAX3–FOXO1 fusion gene in rhabdomyosarcoma
Linardic, C. M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.035 · Cited by 175
Renshaw, J., Taylor, K. R., Bishop, R. T., Valenti, M. R., Brandon, A. D. H., Gowan, S. M., Eccles, S. A., Ruddle, R. R., Johnson, L. D., Raynaud, F. I., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0850 · Cited by 170
Stratton, M. R., Fisher, C., Gusterson, B. A., & Cooper, C. S. (1989) · PubMed · Cited by 168
Paulson, V., Chandler, G. L., Rakheja, D., Galindo, R. L., Wilson, K., Amatruda, J. F., & Cameron, S. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20864 · Cited by 129
RAS signaling dysregulation in human embryonal Rhabdomyosarcoma
Martinelli, S., McDowell, H. P., Vigne, S. D., Kokai, G. K., Uccini, S., Tartaglia, M., & Dominici, C. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20702 · Cited by 119
Barr, F. G., Duan, F., Smith, L. M., Gustafson, D. M., Pitts, M., Hammond, S., & Gastier, J. M. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20673 · Cited by 103
Self-citationComputational Techniques for Human Genome Resequencing Using Mated Gapped Reads
Carnevali, P., Baccash, J., Halpern, A. L., Nazarenko, I., Nilsen, G. B., Pant, K. P., Ebert, J. C., Brownley, A., Morenzoni, M., Karpinchyk, V., et al. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2011.0201 · Cited by 87
Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies
Chen, Y., Takita, J., Hiwatari, M., Igarashi, T., Hanada, R., Kikuchi, A., Hongo, T., Taki, T., Ogasawara, M., Shimada, A., et al. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20322 · Cited by 78
Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors
Lagutina, I. V., Conway, S. J., Sublett, J. E., & Grosveld, G. C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7204-7216.2002 · Cited by 78
Reichek, J. L., Duan, F., Smith, L. M., Gustafson, D. M., O’Connor, R. S., Zhang, C., Dunlevy, M. J., Gastier, J. M., & Barr, F. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0091 · Cited by 70
Self-citationIolascon, A., Faienza, M. F., Coppola, B., Rosolen, A., Basso, G., Ragione, F. D., & Schettini, F. (1996) · Genes Chromosomes and Cancer · Cited by 69
Linardic, C. M., Naini, S., Herndon, J. E., Kesserwan, C., Qualman, S. J., & Counter, C. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3210 · Cited by 64
Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo
Lagha, M., Sato, T., Regnault, B., Cumano, A., Zúñiga, A., Licht, J. D., Relaix, F., & BUCKINGHAM, M. E. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-696 · Cited by 58
PAX3-FOXO1 Induces Cannabinoid Receptor 1 to Enhance Cell Invasion and Metastasis
Marshall, A. D., Lagutina, I. V., & Grosveld, G. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0924 · Cited by 52
Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma
Cen, L., Arnoczky, K. J., Hsieh, F.-C., Lin, H.-J., Qualman, S. J., Yu, S., Xiang, H., & Lin, J. (2007) · Modern Pathology · doi:10.1038/modpathol.3800834 · Cited by 46
(1993) · doi:10.1002/1097-0142(19930301)71:5<1904::aid-cncr2820710530>3.0.co;2-x
(1988) · doi:10.1002/1097-0142(19880115)61:2<209::aid-cncr2820610202>3.0.co;2-l
Cited by
Skapek, S. X., Ferrari, A., Gupta, A. A., Lupo, P. J., Butler, E., Shipley, J., Barr, F. G., & Hawkins, D. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0051-2 · Cited by 875
Self-citationThe Genomic Landscape of Pediatric Ewing Sarcoma
Crompton, B. D., Stewart, C., Taylor-Weiner, A., Alexe, G., Kurek, K. C., Calicchio, M. L., Kiezun, A., Carter, S. L., Shukla, S. A., Mehta, S. S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1037 · Cited by 566
Self-citationTirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête-Lalami, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 565
Targeting FGFR Signaling in Cancer
Touat, M., Ileana, E., Postel-Vinay, S., André, F., & Soria, J.-C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2329 · Cited by 524
The landscape and therapeutic relevance of cancer-associated transcript fusions
Yoshihara, K., Wang, Q., Torres-Garcia, W., Zheng, S., Vegesna, R., Kim, H., & Verhaak, R. G. W. (2015) · Oncogene · doi:10.1038/onc.2014.406 · Cited by 450
Metadata
- Authors
- Shern, J. F., Chen, L., Chmielecki, J., Wei, J. S., Patidar, R., Rosenberg, M., Ambrogio, L., Auclair, D., Wang, J., Song, Y. K., Tolman, C., Hurd, L., Liao, H., Zhang, S., Bogen, D., Brohl, A. S., Sindiri, S., Catchpoole, D., Badgett, T., Getz, G., Mora, J., Anderson, J. R., Skapek, S. X., Barr, F. G., Meyerson, M., Hawkins, D. S., & Khan, J.
- Venue
- Cancer Discovery
- Published
- 2014-02-01
- Volume
- 4
- Issue
- 2
- Pages
- 216-231
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2127736279
- Cited by
- 756
- References
- 67
- FWCI
- 40.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.